LicianPro

SCNI stock

Scinai Immunotherapeutics Ltd (SCNI) short interest & short volume · 180K shares short

Scinai Immunotherapeutics Ltd official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

SCNI short interest rose 802.7% to 180K shares in the Oct 15, 2026 report (1.0 days to cover). Daily short volume averaged 41.3% of volume over the last 20 sessions, down from 49.3% the 20 sessions before, the 58th percentile of its own 20-day averages since Sep 23, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
180K
prior 20K
% of float
—
no float on file
Days to cover
1.0
avg vol 5.9M
Change vs prior report
+802.7%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 2)
37.4%
22K of 59K
20-day average
41.3%
prior 49.3%
Percentile vs own history
58th
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026

Short squeeze score (model)

Price since settlement: -47.7%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

SCNI's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · SCNI overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-0221,98058,85437.4%
2026-10-306,02618,14533.2%
2026-10-294,2905,26681.5%
2026-10-2815,53823,96864.8%
2026-10-272,23217,54012.7%
2026-10-2633,17266,27650.0%
2026-10-231,7349,61318.0%
2026-10-2255,22469,63979.3%
2026-10-2133,86883,69940.5%
2026-10-208,01430,70526.1%

Healthcare peers with similar quant ratings

SCNI among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

SCNI short interest FAQ

What is SCNI's short interest?

Scinai Immunotherapeutics Ltd (SCNI) had 180K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.

How many days to cover does SCNI have?

1.0 days: 180K shares short divided by an average daily volume of 5.9M for the Oct 15, 2026 period.

Is SCNI short interest rising or falling?

SCNI short interest rose (+802.7%) from 20K to 180K shares in the Oct 15, 2026 report.

Is SCNI a short squeeze candidate?

Lician's squeeze watch scores SCNI 18 out of 100 (low) from the Oct 15, 2026 report: days to cover 2.5/25, change in short interest vs prior report 15/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of SCNI daily volume is sold short?

41.3% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 58th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was SCNI's latest FINRA short volume?

On Nov 2, 2026, cached FINRA short volume for Scinai Immunotherapeutics Ltd (SCNI) was 21,980 shares, 37.4% of 58,854 total volume.

How many SCNI short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Scinai Immunotherapeutics Ltd (SCNI), from Oct 20, 2026 through Nov 2, 2026.

How did SCNI short volume percent change from the prior cached session?

Cached FINRA short volume for Scinai Immunotherapeutics Ltd (SCNI) moved from 33.2% on Oct 30, 2026 to 37.4% on Nov 2, 2026, up 4.2 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.